Pain
📧 Sign up to get email alerts when something new happens for Pain.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2013-09-19FDA Approved: DISKETS — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for DISKETS (methadone hydrochloride) from Hikma Pharmaceuticals USA Inc.
-
FDA approval · 2013-09-04FDA Approved: BUPRENORPHINE HYDROCHLORIDE — Supplemental Application (PAI Holdings, LLC dba Pharmaceutical Associates, Inc. and dba PAI Pharma)
The FDA approved a supplemental application for buprenorphine hydrochloride submitted by PAI Holdings (dba Pharmaceutical Associates, Inc. a…
-
FDA approval · 2013-09-04FDA Approved: BUPRENORPHINE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved Hikma Pharmaceuticals USA Inc.'s supplemental application for buprenorphine, a generic opioid medication. This approval covers …
-
FDA approval · 2013-08-14FDA Approved: MORPHINE SULFATE — Supplemental Application (Hospira, Inc.)
The FDA approved a supplemental application for Morphine Sulfate from Hospira, Inc. under NDA 202515. This represents regulatory approval of…
-
FDA approval · 2013-08-13FDA Approved: TRAMADOL HYDROCHLORIDE EXTENDED-RELEASE — Supplemental Application (Trigen Laboratories, LLC)
FDA approved a supplemental application for tramadol hydrochloride extended-release from Trigen Laboratories, LLC. This action approves the …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2013-07-29FDA Approved: SPRIX — Supplemental Application (Zyla Life Sciences US LLC)
The FDA has approved a supplemental application for SPRIX (ketorolac tromethamine) from Zyla Life Sciences US LLC.
-
FDA approval · 2013-07-25FDA Approved: BUTRANS — Supplemental Application (Purdue Pharma LP)
FDA approved a supplemental application for Butrans (buprenorphine) from Purdue Pharma LP.
-
FDA approval · 2013-06-26FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (Mylan Institutional LLC)
The FDA approved a supplemental application for methadone hydrochloride from Mylan Institutional LLC, resulting in updated labeling/manufact…
-
FDA approval · 2013-04-26FDA Approved: HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved Amneal Pharmaceuticals of New York LLC's supplemental application for hydrocodone bitartrate and acetaminophen, an opioid analg…
-
FDA approval · 2013-04-19FDA Approved: FENTANYL — Supplemental Application (Aveva Drug Delivery Systems Inc.)
FDA approved a supplemental application for fentanyl submitted by Aveva Drug Delivery Systems, indicating approval of a revised fentanyl del…
-
FDA approval · 2013-04-15FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (VistaPharm, LLC)
FDA approved a supplemental application for Methadone Hydrochloride manufactured by VistaPharm, LLC.
-
FDA approval · 2013-04-15FDA Approved: BUTRANS — Supplemental Application (Purdue Pharma LP)
FDA approved a supplemental application for BUTRANS (buprenorphine) submitted by Purdue Pharma LP.
-
FDA approval · 2013-04-15FDA Approved: MS CONTIN — Supplemental Application (Rhodes Pharmaceuticals L.P.)
The FDA approved a supplemental application for MS CONTIN (morphine sulfate) from Rhodes Pharmaceuticals L.P.
-
FDA approval · 2013-04-15FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (Ascend Laboratories, LLC)
FDA approved a supplemental application for methadone hydrochloride, a generic product manufactured by Ascend Laboratories, LLC.
-
FDA approval · 2013-04-15FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (SpecGx LLC)
FDA approved a supplemental application for methadone hydrochloride from SpecGx LLC. This approval pertains to a supplemental change to the …
-
FDA approval · 2013-04-15FDA Approved: FENTANYL TRANSDERMAL — Supplemental Application (SpecGx LLC)
The FDA approved a supplemental application for a fentanyl transdermal patch from SpecGx LLC, granting approval of a generic fentanyl transd…
-
FDA approval · 2013-04-15FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved Hikma Pharmaceuticals USA Inc.'s supplemental application for methadone hydrochloride (generic methadone) under ANDA, authorizi…
-
FDA approval · 2013-04-09FDA Approved: TRAMADOL HYDROCHLORIDE EXTENDED-RELEASE — Supplemental Application (Trigen Laboratories, LLC)
FDA approved a supplemental application for Tramadol Hydrochloride Extended-Release submitted by Trigen Laboratories, LLC.
-
FDA approval · 2013-03-29FDA Approved: TRAMADOL HYDROCHLORIDE — Original Application (Cranbury Pharmaceuticals, LLC)
FDA approved the original application for tramadol hydrochloride, a generic analgesic manufactured by Cranbury Pharmaceuticals, LLC.
-
FDA approval · 2013-03-28FDA Approved: KETOROLAC TROMETHAMINE — Supplemental Application (Apotex Corp.)
FDA approved Apotex Corp.'s supplemental application for ketorolac tromethamine, a generic NSAID, to support its use in short-term managemen…
-
FDA approval · 2013-03-08FDA Approved: BUTRANS — Supplemental Application (Purdue Pharma LP)
FDA approved a supplemental application for Butrans (buprenorphine) submitted by Purdue Pharma LP.
-
FDA approval · 2013-02-21FDA Approved: BUPRENORPHINE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for buprenorphine from Hikma Pharmaceuticals USA Inc., resulting in modifications to an already appr…
-
FDA approval · 2013-02-14FDA Approved: FENTANYL — Supplemental Application (Aveva Drug Delivery Systems Inc.)
FDA approved a supplemental application for fentanyl submitted by Aveva Drug Delivery Systems Inc., updating the marketing authorization for…
-
FDA approval · 2013-01-16FDA Approved: MORPHINE SULFATE — Original Application (Actavis Pharma, Inc.)
FDA approved Morphine Sulfate as an original generic ANDA for Actavis Pharma, enabling a generic formulation for pain management.
-
FDA approval · 2012-12-19FDA Approved: PRIALT — Supplemental Application (TerSera Therapeutics LLC)
The FDA approved a supplemental application for PRIALT (ziconotide acetate) submitted by TerSera Therapeutics LLC.